Tag: CIRSE
WAVE trial six-month data show “tremendous” results for WRAPSODY
The six-month results of the WAVE (WRAPSODY Arteriovenous Access Efficacy) pivotal trial have reported superior target lesion primary patency (TLPP) with the WRAPSODY (Merit...
DCB vs plain balloon AV access angioplasty: More investigation is needed,...
At the recent Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual meeting (14–18 September, Lisbon, Portugal), Kate Steiner (East and North Herts NHS...
Merit Medical’s Wrapsody WAVE trial demonstrates superior patency versus standard of...
Merit Medical has today announced positive six-month findings from the randomised arteriovenous (AV) fistula arm of its Wrapsody Arteriovenous Access Efficacy (WAVE) pivotal trial....
The role of the EVA meeting and what we are trying...
Dimitrios Karnabatidis, Konstantinos Katsanos, and Panos Kitrou (University of Patras, Patras, Greece), the directors of the Endo Vascular Access (EVA) meeting, together write about...
VOLA II trial results to ‘change practice’ and ‘improve outcomes’
“We wanted to find a common language between interventional radiologists and nephrologists and we wanted to be sure that the angioplasty we have done...
“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...
Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...